Document Format Files
Seq | Description | Document | Type | Size |
---|---|---|---|---|
1 | FORM 6-K | f6k090519_aptorum.htm | 6-K | 21514 |
2 | PRESS RELEASE DATED SEPTEMBER 9, 2019: APTORUM GROUP LIMITED REPORTS FINANCIAL R | f6k090519ex99-1_aptorum.htm | EX-99.1 | 71507 |
3 | CORPORATE PRESENTATION | f6k090519ex99-2_aptorum.htm | EX-99.2 | 34747 |
4 | PRESS RELEASE DATED SEPTEMBER 9, 2019: APTORUM GROUP HAS INITIATED IND-ENABLING | f6k090519ex99-3_aptorum.htm | EX-99.3 | 15251 |
5 | PRESS RELEASE DATED SEPTEMBER 9, 2019: APTORUM GROUP ANNOUNCES THE DEVELOPMENT O | f6k090519ex99-4_aptorum.htm | EX-99.4 | 19579 |
6 | GRAPHIC | image_001.jpg | GRAPHIC | 7031 |
7 | GRAPHIC | image_002.jpg | GRAPHIC | 7031 |
8 | GRAPHIC | ex99-2_001.jpg | GRAPHIC | 408431 |
9 | GRAPHIC | ex99-2_002.jpg | GRAPHIC | 275139 |
10 | GRAPHIC | ex99-2_003.jpg | GRAPHIC | 282755 |
11 | GRAPHIC | ex99-2_004.jpg | GRAPHIC | 342229 |
12 | GRAPHIC | ex99-2_005.jpg | GRAPHIC | 303856 |
13 | GRAPHIC | ex99-2_006.jpg | GRAPHIC | 340819 |
14 | GRAPHIC | ex99-2_007.jpg | GRAPHIC | 214402 |
15 | GRAPHIC | ex99-2_008.jpg | GRAPHIC | 284046 |
16 | GRAPHIC | ex99-2_009.jpg | GRAPHIC | 168424 |
17 | GRAPHIC | ex99-2_010.jpg | GRAPHIC | 487720 |
18 | GRAPHIC | ex99-2_011.jpg | GRAPHIC | 412077 |
19 | GRAPHIC | ex99-2_012.jpg | GRAPHIC | 464146 |
20 | GRAPHIC | ex99-2_013.jpg | GRAPHIC | 331645 |
21 | GRAPHIC | ex99-2_014.jpg | GRAPHIC | 277734 |
22 | GRAPHIC | ex99-2_015.jpg | GRAPHIC | 241205 |
23 | GRAPHIC | ex99-2_016.jpg | GRAPHIC | 393033 |
24 | GRAPHIC | ex99-2_017.jpg | GRAPHIC | 322314 |
25 | GRAPHIC | ex99-2_018.jpg | GRAPHIC | 291285 |
26 | GRAPHIC | ex99-2_019.jpg | GRAPHIC | 255167 |
27 | GRAPHIC | ex99-2_020.jpg | GRAPHIC | 167986 |
28 | GRAPHIC | ex99-2_021.jpg | GRAPHIC | 180369 |
29 | GRAPHIC | ex99-2_022.jpg | GRAPHIC | 173012 |
30 | GRAPHIC | ex99-2_023.jpg | GRAPHIC | 259551 |
31 | GRAPHIC | ex99-2_024.jpg | GRAPHIC | 191490 |
32 | GRAPHIC | ex99-2_025.jpg | GRAPHIC | 283675 |
33 | GRAPHIC | ex99-2_026.jpg | GRAPHIC | 334746 |
34 | GRAPHIC | ex99-2_027.jpg | GRAPHIC | 337227 |
35 | GRAPHIC | ex99-2_028.jpg | GRAPHIC | 260881 |
36 | GRAPHIC | ex99-2_029.jpg | GRAPHIC | 254792 |
37 | GRAPHIC | ex99-2_030.jpg | GRAPHIC | 350118 |
38 | GRAPHIC | ex99-2_031.jpg | GRAPHIC | 250290 |
39 | GRAPHIC | ex99-2_032.jpg | GRAPHIC | 274368 |
40 | GRAPHIC | ex99-2_033.jpg | GRAPHIC | 188689 |
41 | GRAPHIC | ex99-2_034.jpg | GRAPHIC | 397382 |
42 | GRAPHIC | ex99-2_035.jpg | GRAPHIC | 250967 |
43 | GRAPHIC | ex99-2_036.jpg | GRAPHIC | 226263 |
44 | GRAPHIC | ex99-2_037.jpg | GRAPHIC | 201517 |
45 | GRAPHIC | ex99-2_038.jpg | GRAPHIC | 211495 |
46 | GRAPHIC | ex99-2_039.jpg | GRAPHIC | 147035 |
47 | GRAPHIC | ex99-2_040.jpg | GRAPHIC | 225847 |
48 | GRAPHIC | ex99-2_041.jpg | GRAPHIC | 352293 |
49 | GRAPHIC | ex99-2_042.jpg | GRAPHIC | 253468 |
50 | GRAPHIC | ex99-2_043.jpg | GRAPHIC | 350746 |
51 | GRAPHIC | ex99-2_044.jpg | GRAPHIC | 299334 |
52 | GRAPHIC | ex99-2_045.jpg | GRAPHIC | 194066 |
53 | GRAPHIC | ex99-2_046.jpg | GRAPHIC | 225091 |
54 | GRAPHIC | ex99-2_047.jpg | GRAPHIC | 180729 |
55 | GRAPHIC | ex99-2_048.jpg | GRAPHIC | 370834 |
56 | GRAPHIC | ex99-2_049.jpg | GRAPHIC | 228164 |
57 | GRAPHIC | ex99-2_050.jpg | GRAPHIC | 183557 |
58 | GRAPHIC | ex99-2_051.jpg | GRAPHIC | 223873 |
59 | GRAPHIC | ex99-2_052.jpg | GRAPHIC | 286951 |
60 | GRAPHIC | ex99-2_053.jpg | GRAPHIC | 256827 |
61 | GRAPHIC | ex99-2_054.jpg | GRAPHIC | 517428 |
62 | GRAPHIC | ex99-2_055.jpg | GRAPHIC | 60624 |
63 | GRAPHIC | ex99-4_001.jpg | GRAPHIC | 8762 |
Complete submission text file | 0001213900-19-017442.txt | 20123585 |
IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38764 | Film No.: 191080755
SIC: 2834 Pharmaceutical Preparations